Pure Global AI
Manufacturer profile

CELL MARQUE CORPORATION

BrazilUnited States19 ANVISA registrations10 unique technical categoriesJul 06, 2009 – Jul 06, 2026
19
Total products
10
Technical names
Jul 2009
Earliest registration
Jul 2026
Latest registration
Regulatory footprint
Search CELL MARQUE CORPORATION across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Top registration holders
Companies holding product registrations for this manufacturer
Top competitors
Companies with the most overlapping products (same technical names)
VENTANA MEDICAL SYSTEM, INC
United States
19 registrations8 shared products
Shared products
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - MARKERS OF NERVOUS SYSTEM CARCINOMAS, IMMUNOHISTOCHEMISTRY - MUSCLE CARCINOMA AND MUSCULAR DISORDER MARKERS, IMMUNOHISTOCHEMISTRY - PROSTATE CARCINOMA MARKERS
LEICA BIOSYSTEMS NEWCASTLE LTD
United Kingdom
8 registrations8 shared products
Shared products
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - MARKERS OF NERVOUS SYSTEM CARCINOMAS, IMMUNOHISTOCHEMISTRY - MUSCLE CARCINOMA AND MUSCULAR DISORDER MARKERS, IMMUNOHISTOCHEMISTRY - PROSTATE CARCINOMA MARKERS
AGILENT TECHNOLOGIES, INC.
United States
10 registrations6 shared products
Shared products
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - PROSTATE CARCINOMA MARKERS
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.
Singapore
7 registrations6 shared products
Shared products
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - MARKERS OF NERVOUS SYSTEM CARCINOMAS, IMMUNOHISTOCHEMISTRY - MUSCLE CARCINOMA AND MUSCULAR DISORDER MARKERS
ROCHE DIAGNOSTICS GMBH
Germany
28 registrations4 shared products
Shared products
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS III, HERPES VIRUS (HHV 1), IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS
About this profile

Explore comprehensive manufacturer profile for CELL MARQUE CORPORATION based in United States through Pure Global AI's free Brazil medical device database. This manufacturer has 19 products registered with ANVISA across 10 unique technical categories. Their regulatory history spans from Jul 06, 2009 to Jul 06, 2026.

This page provides detailed insights including 5 recent product registrations including COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS III, 5 most popular products with IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL having 5 registrations, 2 registration holders including ROCHE DIAGNÓSTICA BRASIL LTDA, and 5 key competitors with VENTANA MEDICAL SYSTEM, INC sharing 8 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.